Sanofi

News

Sanofi, CytoReason expand AI deal into IBD

Tech company CytoReason has announced it has signed a multi-year, multimillion dollar deal with Sanofi to deliver artificial intelligence (AI) for drug discovery and development in the fiel

News

Evergreen Sanofi Ventures increases to $750M with further Sa...

Sanofi Ventures – focused on early-to-mid stage investing, company co-creation, leading financing rounds, and prioritising those companies advancing innovation – has announced an

News

FDA starts review of Sanofi, AZ antibody for RSV prevention

The clock has started ticking on the FDA's review of Sanofi and AstraZeneca's one-shot antibody to protect newborns and infants from respiratory syncytial virus (RSV), with a decision due i

News

FDA slaps partial hold on Biogen, InnoCare MS drug

Biogen's efforts to replenish its multiple sclerosis pipeline have suffered a setback, after the FDA placed a clinical hold on a drug candidate it licensed from China's InnoCare last year f

News

Amgen agrees $26bn for Horizon following Sanofi withdrawal

In a fresh update, Bloomberg has reported that US biotech Amg

News

Sanofi backs out of $500m cancer alliance with Revolution

Sanofi has walked away from a four-year-old partnership with Revolution Medicines focused on an SHP2 inhibitor, intended as a combination with KRAS inhibitors, including Sanofi’s Mirati-par

Sanofi, CytoReason expand AI deal into IBD

Evergreen Sanofi Ventures increases to $750M with further Sa...

FDA starts review of Sanofi, AZ antibody for RSV prevention

FDA slaps partial hold on Biogen, InnoCare MS drug

Amgen agrees $26bn for Horizon following Sanofi withdrawal

Sanofi backs out of $500m cancer alliance with Revolution

CEPI steps in to fund Moderna's pandemic flu jab

How to meet your physicians where they are online

Sanofi

Editor's Picks